Condition

CML (2)

ALL (1)

AML (1)

Acute Lymphoblastic Leukemia (1)

Acute Myeloid Leukemia (1)

Blast-phase Chronic Myelogenous Leukemia (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

Synta Pharmaceuticals Corp. (1)

Collaborator

Intervention

nilotinib (1)

sta-9090 (ganetespib) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

CML

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CML Trial in United States (nilotinib)

Completed

CML

nilotinib

Birmingham, Alabama
+53 more

Feb 25, 2020

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Blast-phase Chronic Myelogenous Leukemia Trial in Tampa, Baltimore, Durham

Completed

Acute Myeloid Leukemia
+5 more

STA-9090 (ganetespib)

Tampa, Florida
+2 more

Sep 17, 2014